ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 164 filers reported holding ADMA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,516 | -3.0% | 10,200 | 0.0% | 0.04% | +2.9% |
| Q2 2023 | $37,638 | +11.5% | 10,200 | 0.0% | 0.04% | +12.9% |
| Q1 2023 | $33,762 | -14.7% | 10,200 | 0.0% | 0.03% | -20.5% |
| Q4 2022 | $39,576 | +58.3% | 10,200 | 0.0% | 0.04% | +39.3% |
| Q3 2022 | $25,000 | +19.0% | 10,200 | -1.9% | 0.03% | +27.3% |
| Q2 2022 | $21,000 | +10.5% | 10,400 | 0.0% | 0.02% | +37.5% |
| Q1 2022 | $19,000 | +26.7% | 10,400 | 0.0% | 0.02% | +23.1% |
| Q4 2021 | $15,000 | +25.0% | 10,400 | -1.0% | 0.01% | +18.2% |
| Q3 2021 | $12,000 | -29.4% | 10,500 | 0.0% | 0.01% | -26.7% |
| Q2 2021 | $17,000 | -5.6% | 10,500 | 0.0% | 0.02% | -11.8% |
| Q1 2021 | $18,000 | – | 10,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |